These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 550940)

  • 1. Antiopyrine half-life as a measure of hepatic enzyme induction: clinical applications in a chronic epileptic population.
    Byrne E; Harman AW; Frewin DB; Hallpike JF
    Clin Exp Neurol; 1979; 16():183-9. PubMed ID: 550940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Ginkgo biloba extract on microsomal enzyme induction.
    Duche JC; Barre J; Guinot P; Duchier J; Cournot A; Tillement JP
    Int J Clin Pharmacol Res; 1989; 9(3):165-8. PubMed ID: 2744909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipyrine disposition in relation to lowered anticonvulsant plasma level during pregnancy.
    Chiba K; Ishizaki T; Tabuchi T; Wagatsuma T; Nakazawa Y
    Obstet Gynecol; 1982 Nov; 60(5):620-6. PubMed ID: 6815599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum LDL cholesterol, the LDL/HDL cholesterol ratio and liver microsomal enzyme induction evaluated by antipyrine kinetics.
    Luoma PV; Sotaniemi EA; Arranto AJ
    Scand J Clin Lab Invest; 1983 Dec; 43(8):671-5. PubMed ID: 6665516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical significance of microsomal enzyme induction in the therapy of epileptic patients.
    Sotaniemi E; Arvela P; Hakkarainen H; Huhti E
    Ann Clin Res; 1970 Sep; 2(3):223-7. PubMed ID: 5473162
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction of hepatic microsomal enzymes after brief administration of rifampicin in man.
    Miguet JP; Mavier P; Soussy CJ; Dhumeaux D
    Gastroenterology; 1977 May; 72(5 Pt 1):924-6. PubMed ID: 849823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical application of antipyrine half life in saliva in a patient with osteomalacia.
    Fraser HS; Thompson D; Khan C
    Br Med J; 1976 Jun; 1(6024):1507-8. PubMed ID: 6110
    [No Abstract]   [Full Text] [Related]  

  • 8. Microsomal enzyme induction by permethrin in rats.
    Anadon A; Diez MJ; Sierra M; Sanchez JA; Teran MT
    Vet Hum Toxicol; 1988 Aug; 30(4):309-12. PubMed ID: 2902710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipyrine metabolism in lung cancer patients and their relatives.
    Radzikowska E; Gazdzik W; Rowińska-Zakrzewska E
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():297-308. PubMed ID: 9337547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Enhanced drug hydroxylation in man under diphenyl-hydantoin therapy].
    Petruch F; Schüppel RV
    Arzneimittelforschung; 1974 Jul; 24(7):1023-5. PubMed ID: 4211429
    [No Abstract]   [Full Text] [Related]  

  • 11. Genotoxicity of the anticonvulsant drug phenytoin (PHT): a follow-up study of PHT-untreated epileptic patients. I. Sister chromatid exchange (SCE) analysis.
    Kaul A; Goyle S
    Teratog Carcinog Mutagen; 1999; 19(1):61-72. PubMed ID: 10321411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged use of phenytoin, carbamazepine or valproate monotherapy on plasma levels of folate and B(12): a comparison between epileptic patients with or without cardiovascular disorders.
    Otoom S; Bakhiet M; Khan A; Sequeira R
    Neuro Endocrinol Lett; 2006; 27(1-2):85-8. PubMed ID: 16648782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of anticonvulsive treatment on drug elimination in man. Induction of liver hydroxylating enzyme system by diphenylhydantoin and carbamazepine].
    Petruch F; Schüppel RV
    Bibl Psychiatr; 1975; (151):76-81. PubMed ID: 1156351
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes of thyroid hormone levels in epileptic patients.
    Zhu SQ; Liu XM; Ruan XZ; Cai Z
    J Tongji Med Univ; 1994; 14(2):119-23. PubMed ID: 7966515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of antipyrine and phenytoin correlated with age and liver volume in man.
    Bach B; Hansen JM; Kampmann JP; Rasmussen SN; Skovsted L
    Clin Pharmacokinet; 1981; 6(5):389-96. PubMed ID: 7333060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary antipyrine kinetics in hepatic and renal disease and in patients on anticonvulsant therapy.
    Harman AW; Penhall RK; Priestly BG; Frewin DB; Phillips PJ; Clarkson AR
    Aust N Z J Med; 1977 Aug; 7(4):385-90. PubMed ID: 270989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The assessment of liver microsomal oxidative capacity via caffeine and antipyrine elimination in patients with chronic active hepatitis: preliminary results].
    Soto Alvarez J; Alsar Ortiz MJ
    An Med Interna; 1992 Nov; 9(11):547-50. PubMed ID: 1467403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetazolamide-accelerated anticonvulsant osteomalacia.
    Mallette LE
    Arch Intern Med; 1977 Aug; 137(8):1013-7. PubMed ID: 879939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology of mephenytoin and ethotoin.
    Troupin AS; Friel P; Lovely MP; Wilensky AJ
    Ann Neurol; 1979 Nov; 6(5):410-4. PubMed ID: 42344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients.
    Perucca E; Hedges A; Makki KA; Ruprah M; Wilson JF; Richens A
    Br J Clin Pharmacol; 1984 Sep; 18(3):401-10. PubMed ID: 6435654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.